139 related articles for article (PubMed ID: 33134121)
1. Impact and operational feasibility of TrueNat
Jeyashree K; Shanmugasundaram D; Rade K; Gangakhedkar RR; Murhekar MV
Public Health Action; 2020 Sep; 10(3):87-91. PubMed ID: 33134121
[TBL] [Abstract][Full Text] [Related]
2. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients.
Gomathi NS; Singh M; Myneedu VP; Chauhan DS; Tripathy S; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; V Rao MV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Singh UB
Indian J Med Res; 2020 Nov; 152(5):482-489. PubMed ID: 33707390
[TBL] [Abstract][Full Text] [Related]
3. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
Lee DJ; Kumarasamy N; Resch SC; Sivaramakrishnan GN; Mayer KH; Tripathy S; Paltiel AD; Freedberg KA; Reddy KP
PLoS One; 2019; 14(7):e0218890. PubMed ID: 31265470
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India.
Gopalaswamy R; Kumar N; Vashistha H; Rajendran P; Kayesth J; Peravali CJ; Kashyap S; Ghosh S; Yumo H; Moore M; Anand S; Ramachandran R; Alavadi U; Saini S; Shanmugam S
Front Public Health; 2023; 11():1255756. PubMed ID: 37886056
[TBL] [Abstract][Full Text] [Related]
5. Multicentric validation of indigenous molecular test Truenat™ MTB for detection of
Gomathi NS; Singh M; Singh UB; Myneedu VP; Chauhan DS; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; Rao MVV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Tripathy S
Indian J Med Res; 2020 Oct; 152(4):378-385. PubMed ID: 33380702
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to gene XPERT MTB/RIF ultra for the diagnosis of pulmonary tuberculosis in Uganda.
Ssengooba W; Katamba A; Sserubiri J; Semugenze D; Nyombi A; Byaruhanga R; Turyahabwe S; Joloba ML
BMC Infect Dis; 2024 Feb; 24(1):190. PubMed ID: 38350885
[TBL] [Abstract][Full Text] [Related]
7. A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays.
Penn-Nicholson A; Gomathi SN; Ugarte-Gil C; Meaza A; Lavu E; Patel P; Choudhury B; Rodrigues C; Chadha S; Kazi M; Macé A; Nabeta P; Boehme C; Gangakhedkar RR; Sarin S; Tesfaye E; Gotuzzo E; du Cros P; Tripathy S; Ruhwald M; Singh M; Denkinger CM; Schumacher SG; ;
Eur Respir J; 2021 Oct; 58(5):. PubMed ID: 34049948
[TBL] [Abstract][Full Text] [Related]
8. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
[TBL] [Abstract][Full Text] [Related]
9. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
[TBL] [Abstract][Full Text] [Related]
10. Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF.
Singh UB; Singh M; Sharma S; Mahajan N; Bala K; Srivastav A; Singh KJ; Rao MVV; Lodha R; Kabra SK
Sci Rep; 2023 Apr; 13(1):6976. PubMed ID: 37117209
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of the Truenat MTB Plus Assay and Comparison with the Xpert MTB/RIF Assay to Detect Tuberculosis among Hospital Outpatients in Cameroon.
Ngangue YR; Mbuli C; Neh A; Nshom E; Koudjou A; Palmer D; Ndi NN; Qin ZZ; Creswell J; Mbassa V; Vuchas C; Sander M
J Clin Microbiol; 2022 Aug; 60(8):e0015522. PubMed ID: 35861529
[TBL] [Abstract][Full Text] [Related]
12. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
[TBL] [Abstract][Full Text] [Related]
13. Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population.
Raizada N; Sachdeva KS; Swaminathan S; Kulsange S; Khaparde SD; Nair SA; Khanna A; Chopra KK; Hanif M; Sethi GR; Umadevi KR; Keshav Chander G; Saha B; Shah A; Parmar M; Ghediya M; Jaju J; Boehme C; Paramasivan CN
PLoS One; 2015; 10(10):e0140375. PubMed ID: 26469691
[TBL] [Abstract][Full Text] [Related]
14. Impact of Xpert MTB/RIF in the Diagnosis of Childhood Tuberculosis in Rural Ethiopia.
Pérez-Butragueño M; Ramos-Rincón JM; Tesfamariam A; Comeche B; Mohammed N; Tiziano G; Endirays J; Biru D; Elala T; Edri A; Prieto L; Górgolas M
J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35848941
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of extrapulmonary tuberculosis by GeneXpert MTB/RIF Ultra assay.
Dahiya B; Mehta N; Soni A; Mehta PK
Expert Rev Mol Diagn; 2023; 23(7):561-582. PubMed ID: 37318829
[TBL] [Abstract][Full Text] [Related]
16. Evaluating Truenat Assay for the Diagnosis of Ocular Tuberculosis and Detection of Drug Resistance.
Sharma K; Sharma M; Ayyadurai N; Dogra M; Sharma A; Gupta V; Singh R; Gupta A
Ocul Immunol Inflamm; 2023 Feb; ():1-7. PubMed ID: 36726220
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Currently Available Diagnostic Tools for Diagnosis of Pediatric Tuberculosis Under National Tuberculosis Elimination Program.
Bhatia R; Chauhan A; Kaur K; Rana M; Singh M
Indian J Community Med; 2023; 48(1):24-30. PubMed ID: 37082404
[TBL] [Abstract][Full Text] [Related]
18. Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE).
Leukes VN; Hella J; Sabi I; Cossa M; Khosa C; Erkosar B; Mangu C; Siyame E; Mtafya B; Lwilla A; Viegas S; Madeira C; Machiana A; Ribeiro J; Garcia-Basteiro AL; Riess F; Elísio D; Sasamalo M; Mhalu G; Denkinger CM; Castro MDM; Bashir S; Schumacher SG; Tagliani E; Malhotra A; Dowdy D; Schacht C; Buech J; Nguenha D; Ntinginya N; Ruhwald M; Penn-Nicholson A; Kranzer K;
BMC Infect Dis; 2024 Jan; 24(1):107. PubMed ID: 38243223
[TBL] [Abstract][Full Text] [Related]
19. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
Engel N; Ochodo EA; Karanja PW; Schmidt BM; Janssen R; Steingart KR; Oliver S
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014877. PubMed ID: 35470432
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis.
Nikam C; Kazi M; Nair C; Jaggannath M; M M; R V; Shetty A; Rodrigues C
Int J Mycobacteriol; 2014 Sep; 3(3):205-10. PubMed ID: 26786489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
